Business Wire

NV-LENOVO

5.1.2023 17:37:35 CET | Business Wire | Press release

Share
Lenovo Introduces Feature-Packed Devices and Solutions at CES that Deliver Users a More Personalized Experience

Today at CES® 2023, Lenovo™ unveiled the latest lineup of devices and solutions focused on innovation and improving the user experience. From new form factors, beautiful design-led products, and innovative uses of AI, the new portfolio gives consumers and business users a more personalized technology experience.

The new portfolio also demonstrates Lenovo’s commitment to ESG in line with its vision of achieving net-zero by 2050 aligned to Science Based Target initiatives, Lenovo continues to focus on supporting a circular economy by increasing the use of recycled materials in its products and packaging, and collaborating with industry partners to help increase energy efficiency of its devices

Premium Consumer Devices Spotlight Innovation in Unexpected Ways

Lenovo introduced bold new products to address the wide-ranging needs of the modern consumer. The new, cutting-edge Yoga Book 9i hails a new chapter for Yoga with incredible innovation, premium style, and performance for versatile experiences. Redefining what an all-in-one desktop computer could look like, with the design-led Yoga AIO 9i. The new Yoga Slim 6i (14”, 8), known as Lenovo Slim 7 (14”, 8) in the U.S., is an exquisitely designed, portable, yet powerful device. Thin, lightweight, and attractive, this laptop empowers users to work and create content easily, whether on the move or at home.

Lenovo also introduced refreshes of its Yoga 9i (14”, 8) and Yoga Slim 7i Carbon (13”, 8), both featuring up to 13th Gen Intel Core processors, delivering an even more impressive performance to enhance versatility and productivity. Also, the refreshed Yoga 6 (13”, 8) laptop is power-forward and refreshed with the latest AMD Ryzen™ 7000 series processors and enhanced battery to handle longer remote work sessions.

In tablets, the feature-rich Lenovo Tab Extreme and Lenovo Smart Paper digital notepad deliver exciting capabilities for school, home, and beyond. The Lenovo Tab Extreme is Lenovo’s biggest and most powerful tablet yet, featuring a dual-hinge keyboard design2; unique, protective storage compartment is created within the main hinge of the stand for the included Lenovo Precision Pen 3.

Lenovo’s Project Chronos concept (formal name forthcoming) is a new technology that captures a user’s movement. It enables them to interact with and perform activities in 3D virtual worlds without glasses or wearables, making it easier than ever before for users to enter 3D-rendered virtual environments.

Innovative Technology for SMBs With a Twist

Lenovo announced an innovative new model in the ThinkBook Plus series that reimagines its strong heritage of the twistable form factor, with a dual rotating display that features an OLED panel on one side and a colorful e-Ink screen on the other. Lenovo also unveiled its latest ThinkBook 16p Gen 4 laptop powered by high performance components. This device features an innovative Lenovo Magic Bay modular accessory design with magnetic pin connector allowing easy expansion for optionally included Lenovo Magic Bay 4K Webcam, Lenovo Magic Bay LTE or Lenovo Magic Bay Light accessories.

Also, Lenovo introduced a new ThinkBook 13x Gen 2 Wireless Dock combining several wireless technologies to create a virtually cable-free docking and charging solution. Finally, Lenovo unveiled the latest in the portfolio of Tiny form factors. ThinkCentre neo 50q is a 1L space-saving desktop designed specifically for SMB customers.

Stylish and Smarter Ecosystem of Gaming Products

The 2023 Lenovo Legion lineup of battle-ready PCs, monitors, and accessories set a new standard in PC gaming that give gamers the edge they need to top leaderboards. New for 2023 is the Lenovo LA AI chip, the world’s first dedicated AI chip on a gaming laptop3, installed on the Lenovo Legion Pro 7 and 7i (16”, 8) laptops and the Lenovo Legion Pro 5 and 5i (16”, 8) laptops. Lenovo AI Engine+, powered by the Lenovo LA AI chip, deploys a software machine learning algorithm to optimally tune system performance.

On the desktop front, the new generation of Lenovo Legion towers stand at the pinnacle of extreme power and performance, with the Lenovo Legion Tower 7i (34L, 8) and Lenovo Legion Tower 5i (26L, 8) featuring up to 13th Gen Intel® Core™ desktop processors and NVIDIA® GeForce RTX™ 40 Series GPUs, while the Lenovo Legion Tower 5 (26L, 8) features up to AMD® Ryzen™ 9 processor and AMD Radeon™ RX 7000 series or NVIDIA GeForce RTX 40 Series GPUs. To round out the portfolio, Lenovo Legion’s newest monitors include the new 27-inch Lenovo Legion Y27f-30 FHD and 27-inch Lenovo Legion Y27qf-30 QHD displays that are engineered to meet the demands of gamers and content creators alike.

ThinkPad X1, ThinkPhone, ThinkVision and Lenovo Go Power Hybrid Working

Lenovo revealed its latest ThinkPad X1 laptops featuring recycled materials1, updated Lenovo Commercial Vantage software designed to highlight settings that can improve energy efficiency, and a new Lenovo View application, offering advanced computer vision technology for enhanced video image quality and tools for collaboration, security, and digital wellness. The latest line of ThinkVision monitors leads with the ultra-bright ThinkVision P27pz-30 and P32pz-30 mini-LED displays followed by ThinkVision’s new T-series VOIP monitors built for hybrid work, featuring an integrated Microsoft Teams functionality, 5MP cameras, dual microphones, and speakers. Lenovo also introduced its latest professional-grade 4K ThinkVision P-series monitors and, for the home, new value-conscious Lenovo L-series monitors. Completing an efficient hybrid eco-system are new accessories, including the unique Lenovo Go Desk Station, Lenovo Go 4K Pro Webcam, and Lenovo Professional Wireless Rechargeable Combo Keyboard and Mouse.

In celebrating the recent 30th anniversary of ThinkPad, meet the Lenovo ThinkPhone by Motorola, which is engineered to bring businesses a smartphone experience with the same trusted quality and reliability present on every Lenovo Think-branded device. This device arrives with a set of productivity experiences – Think 2 Think - that allows business end-users to enjoy seamless device integration between ThinkPhone and a ThinkPad. To ensure the device operates at peak performance for years to come, it is packed with the Snapdragon 8+ Gen 1 mobile platform, larger 6.6” FHD+ display and a 68W TurboPower universal charge that is able to charge both the phone and the PC.

Consumer Devices Delivering Next-Gen Features for Performance, Versatility, and Convenience

Lenovo’s latest generation of consumer devices are loaded with standout features and enhancements designed to help people connect with their passions and achieve their daily goals. With five new performance-driving and portable IdeaPad laptops (IdeaPad Pro 5i, IdeaPad Pro 5 Gen 8, IdeaPad Slim 5i, IdeaPad Slim 5 and IdeaPad Flex 3i Chromebook), the sleek and compact IdeaCentre Mini (1L, 8) desktop, a 9-inch Lenovo tablet (Lenovo Tab M9), and the versatile Lenovo 500 USB Type-C Universal Dock, these devices are designed for all the spaces and places in line with the on-the-go lifestyle of today’s consumer. Whether working, studying, creating, or just catching up with friends out of town, these new products offer speed, versatility, and convenience to suit their needs wherever they are.

Supporting Services and Software

In addition to these premium hardware options, Lenovo offers a range of device health, support, and protection services to help keep products running at peak condition and more secure, like its latest cloud-based security software Lenovo Smart Lock4. For an added level of convenience in supporting the laptops introduced today, Lenovo Premium Care Plus5 incorporates many of its services into one solution. This comprehensive service includes advanced hardware and software support, Accidental Damage Protection, an extended battery warranty, Lenovo Migration Assistant, and Lenovo Smart Performance – a self-diagnostic system health check found within Lenovo Vantage.

Lenovo continues 30th anniversary of the ThinkPad at CES 2023

Lenovo is continuing celebrations of ThinkPad's 30th anniversary and bringing a virtual Think On Theater to CES and beyond. The Think On Theater will feature content from our Next 30, including Alice Aedy, Marcus John and Bjarke Ingels. To check out the virtual Think On Theater, visit Lenovo's Virtual Showcase starting January 5.

More info on all of Lenovo’s new product announcements can be found in the CES 2023 press kit on Lenovo StoryHub:

About Lenovo

Lenovo (HKSE: 992) (ADR: LNVGY) is a US$70 billion revenue global technology powerhouse, ranked #171 in the Fortune Global 500, employing 82,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into key growth areas including server, storage, mobile, solutions and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and sustainable digital society for everyone, everywhere. To find out more, visit https://www.lenovo.com and read about the latest news on Lenovo StoryHub.

1 Previous generation ThinkPad X1 Carbon, X1 Yoga and X1 Nano did not use recycled metals

2 Dual-hinge keyboard stand is sold separately in some markets

3 Based on internal research conducted as of October 24, 2022, comparing 16” gaming laptops distributed by global PC manufacturers shipping > 1 million units worldwide annually, and supported by the combination of a dedicated AI chip or AI engine and NVIDIA GeForce RTX TGP (140W+) graphics.

4 Lenovo Smart Lock is available through Lenovo Vantage and only applicable on Lenovo PCs with Windows 10 or 11.

5 Premium Care Plus products are applicable to the desktops, laptops and tablets in this announcement, and are subject to availability. The service is available in select markets and service level may vary by geographic location. Lenovo reserves the right to alter product offerings and specifications at any time, without notice.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230105005201/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye